Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
59,766.18 -3,583.21 (-5.66%) CMC Crypto 200
1,283.73 -55.34 (-4.13%)
VIR Oct 2024 22.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:49AM EDT. Market open.
| Previous close | 0.2900 |
| Open | 0.2900 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 22.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.2900 - 0.2900 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
SAN FRANCISCO, April 30, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities Healthcare Conference 2024 on Tuesday, May 14, at 4:20 p.m. PT / 7:20 p.m. ET.
Simply Wall St.With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
Key Insights Institutions' substantial holdings in Vir Biotechnology implies that they have significant influence over...
ZacksWhat Makes Vir Biotechnology (VIR) a New Buy Stock
Vir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.